Meny

Du är här

BioBanking - The Holy Grail of novel drug and diagnostic developments?

Författare:
Publiceringsår: 2011
Språk: Engelska
Sidor:
Publikation/Tidskrift/Serie: Journal of clinical bioinformatics
Volym: 1
Nummer: 1
Dokumenttyp: Artikel
Förlag: BioMed Central Ltd

Sammanfattning

ABSTRACT: The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.

Disputation

Nyckelord

  • Medicine and Health Sciences

Övriga

Published
Yes
  • ISSN: 2043-9113

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen